9 research outputs found
ΠΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΡΡΡΠΎΠ³Π΅Π½ΠΎΠ² Π² ΡΠΊΠ°Π½ΡΡ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠ½ΠΎΠΉ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ ΠΈ ΡΠ°Π½Π΄Π΅ΠΌΠ½ΠΎΠΉ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΠΈ
Although estrogen contribution estrogen to breast cancer development is not fully understood, an effective method of their measurement, in the mammary gland might provide additional insight. In this study, we have developed a LC-MS/MS method of simultaneous quantification of estrone and estradiol in breast tissue samples. Analytes were extracted with methyl tert-butyl ether by sonication and derivatized with dansyl chloride. Estrogens were analyzed by liquid chromatography-tandem mass spectrometry with an electrospray ionization source. Accuracy and precision were better than 20% for most concentrations. Although estrone and estradiol levels in normal and malignant breast tissue samples analyzed using our method insignificantly differed. The method developed may be used in further studies aimed at evaluating a role estrogens in breast cancer risk.ΠΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΡΡΡΡΠΎΠ³Π΅Π½ΠΎΠ² ΡΡΠΈΡΠ°Π΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΡΡΠΎΠ³ΠΎ ΡΠ°ΠΊΡΠΎΡΠ° Π΄ΠΎ ΠΊΠΎΠ½ΡΠ° Π½Π΅ ΠΈΠ·ΡΡΠ΅Π½Ρ. Π ΡΠ²ΡΠ·ΠΈ Ρ ΡΡΠΈΠΌ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΡΡΡΠΎΠ³Π΅Π½ΠΎΠ² Π² ΡΠΊΠ°Π½ΡΡ
ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΡΡΡΠΎΠ½Π° ΠΈ ΡΡΡΡΠ°Π΄ΠΈΠΎΠ»Π° Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
ΡΠΊΠ°Π½ΠΈ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Π²ΡΡΠΎΠΊΠΎΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠ½ΠΎΠΉ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ Ρ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄Π΅ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. ΠΠ½Π°Π»ΠΈΡΡ ΡΠΊΡΡΡΠ°Π³ΠΈΡΠΎΠ²Π°Π»ΠΈ ΠΌΠ΅ΡΠΈΠ»-ΡΡΠ΅Ρ-Π±ΡΡΠΈΠ»ΠΎΠ²ΡΠΌ ΡΡΠΈΡΠΎΠΌ Π² ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ Π±Π°Π½Π΅ ΠΈ Π΄Π΅ΡΠΈΠ²Π°ΡΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈ Π΄Π°Π½ΡΠΈΠ»Ρ
Π»ΠΎΡΠΈΠ΄ΠΎΠΌ. ΠΡΠ»ΠΈ ΡΠ°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ Π²Π°ΡΠΈΠ°Π½ΡΡ Π½ΠΎΡΠΌΠΈΡΠΎΠ²ΠΊΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
Π½Π° ΠΈΡΡ
ΠΎΠ΄Π½ΡΡ ΠΌΠ°ΡΡΡ ΡΠΊΠ°Π½ΠΈ ΠΈ Π½Π° ΠΌΠ°ΡΡΡ ΡΠΊΡΡΡΠ°Π³ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π»ΠΈΠΏΠΈΠ΄ΠΎΠ². Π’ΠΎΡΠ½ΠΎΡΡΡ ΠΈ ΠΏΡΠ΅ΡΠΈΠ·ΠΈΠΎΠ½Π½ΠΎΡΡΡ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° Π±ΡΠ»ΠΈ Π²ΡΡΠ΅ 20% Π΄Π»Ρ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ. Π‘ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠ΅ΡΠΎΠ΄Π° Π±ΡΠ»ΠΈ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΡΠΎΠ²Π½ΠΈ ΡΡΡΡΠΎΠ½Π° ΠΈ ΡΡΡΡΠ°Π΄ΠΈΠΎΠ»Π° Π² ΠΎΠ±ΡΠ°Π·ΡΠ°Ρ
Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ Π² Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
Π²Π»ΠΈΡΠ½ΠΈΡ ΡΡΡΡΠΎΠ³Π΅Π½Π° Π½Π° ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ
ΠΠ»Π³ΠΎΡΠΈΡΠΌ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ Π΄Π»Ρ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°Π½Π΅Π»ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΠΏΠΎΠΈΡΠΊΠ° ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ
A pathology diagnostic using molecular marker is a perspective direction of clinical medicine. Mass-spectrometry (MS) is a one of methods, which are used for obtaining information about molecular profiles. Selection of species, essential for classification βcase/control is an important task for data processing. Pipeline of data processing has been proposed using MS data, obtained during analysis of tumor breast tissue samples and health breast tissue samples, with the aim of metastasis marker selection. As a result, selection of lipid markers that belong to classes, related to metastasis and proliferation processes, makes it possible to create high sensitivity diagnostic model, based on logistic regression. The proposed method is applicable for data processing, obtained by MS analysis of other βomicsβ: metabolome, proteome, glycome.ΠΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΏΠΎ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΌ ΠΌΠ°ΡΠΊΠ΅ΡΠ°ΠΌ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ, Π² ΠΊΠΎΡΠΎΡΠΎΠΌ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡ (ΠΠ‘) ΡΡΠ»ΡΠΆΠΈΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ², ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΡ
Π΄Π»Ρ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΠΎ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
ΠΏΡΠΎΡΠΈΠ»ΡΡ
. Π ΠΊΠΎΠ½ΡΠ΅ΠΊΡΡΠ΅ ΠΈΠ·Π²Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ, ΠΈΠ³ΡΠ°ΡΡΠΈΡ
ΠΊΠ»ΡΡΠ΅Π²ΡΡ ΡΠΎΠ»Ρ Π΄Π»Ρ ΠΊΠ»Π°ΡΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ/Π±ΠΎΠ»Π΅Π·Π½Ρ, Π²Π°ΠΆΠ½ΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ ΠΈΠΌΠ΅Π΅Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
, ΡΠ°ΡΡΠΎ Π²ΠΊΠ»ΡΡΠ°ΡΡΠΈΡ
Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ ΡΠΎΡΠ΅Π½ Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ. Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½ Π°Π»Π³ΠΎΡΠΈΡΠΌ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ Π΄Π°Π½Π½ΡΡ
Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ Π΄Π°Π½Π½ΡΡ
ΠΠ‘, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΈ Π·Π΄ΠΎΡΠΎΠ²ΠΎΠΉ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ, Ρ ΡΠ΅Π»ΡΡ Π²ΡΠ΄Π΅Π»Π΅Π½ΠΈΡ Π»ΠΈΠΏΠΈΠ΄Π½ΡΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ. Π ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π΅Π³ΠΎ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½ Π½Π°Π±ΠΎΡ ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ, ΠΎΡΠ½ΠΎΡΡΡΠΈΡ
ΡΡ ΠΊ ΠΊΠ»Π°ΡΡΠ°ΠΌ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ², ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ ΠΏΡΠΎΡΠ΅ΡΡΠ°ΠΌΠΈ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠΈ, ΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡΠΈΡ
ΠΏΠΎΡΡΡΠΎΠΈΡΡ Π²ΡΡΠΎΠΊΠΎΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΠΌΠΎΠ΄Π΅Π»Ρ Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ Π»ΠΎΠ³ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅Π³ΡΠ΅ΡΡΠΈΠΈ. ΠΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΠΏΠΎΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΠΎ ΠΏΡΠΈΠ³ΠΎΠ΄Π΅Π½ Π΄Π»Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ Π΄Π°Π½Π½ΡΡ
ΠΠ‘, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΏΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ»Ρ Π±ΠΈΠΎΠΌΠ°ΡΠ΅ΡΠΈΠ°Π»Π° Π΄ΡΡΠ³ΠΎΠ³ΠΎ Π±Π°Π·ΠΈΡΠ° (ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΎΠΌ, ΠΏΡΠΎΡΠ΅ΠΎΠΌ, Π³Π»ΠΈΠΊΠΎΠΌ)
METABOLIC "FOOTPRINTS" OF THE CIRCULATING CANCER MUCINS: CA125 IN THE HIGH-GRADE OVARIAN CANCER
Mucins are large glycoproteins characterized by the abundant O-linked oligosaccharides (O-glycans) clustered on a protein backbone. Most of the circulating mucins are rapidly cleared by glycan-recognizing hepatic clearance receptors in the liver. Those mucins that remain in the bloodstream are most commonly used as markers in clinical diagnostics. One of such circulating mucins is MUC16; a peptide epitope of which is known as CA125 antigen - a marker for ovarian cancer. Here, using a targeted 1H-NMR profiling of plasma we are exploring a link between the measured CA125 values and the systemic metabolism of the patients within a group with confirmed high-grade ovarian cancer. The study allowed identifying statistically significant associations between the measured values of CA125 epitope and the plasma concentrations of glucose, glutamine, alanine, betaine and serine. The significance of the identified associations for the listed compounds is below 0.01. This, in turn, enables us to hypothesize about a possibility of including the metabolic measures into a composite score of the ovarian cancer based on the CA125 epitope of MUC16.Proteomic
METABOLIC "FOOTPRINTS" OF THE CIRCULATING CANCER MUCINS: CA125 IN THE HIGH-GRADE OVARIAN CANCER
Mucins are large glycoproteins characterized by the abundant O-linked oligosaccharides (O-glycans) clustered on a protein backbone. Most of the circulating mucins are rapidly cleared by glycan-recognizing hepatic clearance receptors in the liver. Those mucins that remain in the bloodstream are most commonly used as markers in clinical diagnostics. One of such circulating mucins is MUC16; a peptide epitope of which is known as CA125 antigen - a marker for ovarian cancer. Here, using a targeted 1H-NMR profiling of plasma we are exploring a link between the measured CA125 values and the systemic metabolism of the patients within a group with confirmed high-grade ovarian cancer. The study allowed identifying statistically significant associations between the measured values of CA125 epitope and the plasma concentrations of glucose, glutamine, alanine, betaine and serine. The significance of the identified associations for the listed compounds is below 0.01. This, in turn, enables us to hypothesize about a possibility of including the metabolic measures into a composite score of the ovarian cancer based on the CA125 epitope of MUC16
METABOLIC βFOOTPRINTSβ OF THE CIRCULATING CANCER MUCINS: CA125 IN THE HIGH-GRADE OVARIAN CANCER
METABOLIC βFOOTPRINTSβ OF THE CIRCULATING CANCER MUCINS: CA125 IN THE HIGH-GRADE OVARIAN CANCER [ΠΠΠ’ΠΠΠΠΠΠΠΠΠ― ΠΠΠΠΠΠ‘Π¬ Π‘ΠΠΠΠΠΠΠ«Π₯ ΠΠ£Π¦ΠΠΠΠ ΠΠ Π ΠΠΠΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ₯ ΠΠΠΠΠΠΠΠΠΠΠ―Π₯: Π‘Π125 Π Π ΠΠ Π―ΠΠ§ΠΠΠΠΠ ΠΠ«Π‘ΠΠΠΠ Π‘Π’ΠΠΠΠΠ ΠΠΠΠΠΠ§ΠΠ‘Π’ΠΠΠΠΠΠ‘Π’Π]
Mucins are large glycoproteins characterized by the abundant O-linked oligosaccharides (O-glycans) clustered on a protein backbone. Most of the circulating mucins are rapidly cleared by glycan-recognizing hepatic clearance receptors in the liver. Those mucins that remain in the bloodstream are most commonly used as markers in clinical diagnostics. One of such circulating mucins is MUC16; a peptide epitope of which is known as CA125 antigen β a marker for ovarian cancer. Here, using a targeted 1H-NMR profiling of plasma we are exploring a link between the measured CA125 values and the systemic metabolism of the patients within a group with confirmed high-grade ovarian cancer. The study allowed identifying statistically significant associations between the measured values of CA125 epitope and the plasma concentrations of glucose, glutamine, alanine, betaine and serine. The significance of the identified associations for the listed compounds is below 0.01. This, in turn, enables us to hypothesize about a possibility of including the metabolic measures into a composite score of the ovarian cancer based on the CA125 epitope of MUC16. Β© 2021 Pirogov Russian National Research Medical University. All rights reserved
Genetic diversity of SAD and FAD genes responsible for the fatty acid composition in flax cultivars and lines
Background: Flax (Linum usitatissimum L.) is grown for fiber and seed in many countries. Flax cultivars differ in the oil composition and, depending on the ratio of fatty acids, are used in pharmaceutical, food, or paint industries. It is known that genes of SAD (stearoyl-ACP desaturase) and FAD (fatty acid desaturase) families play a key role in the synthesis of fatty acids, and some alleles of these genes are associated with a certain composition of flax oil. However, data on genetic polymorphism of these genes are still insufficient. Results: On the basis of the collection of the Institute for Flax (Torzhok, Russia), we formed a representative set of 84 cultivars and lines reflecting the diversity of fatty acid composition of flax oil. An approach for the determination of full-length sequences of SAD1, SAD2, FAD2A, FAD2B, FAD3A, and FAD3B genes using the Illumina platform was developedΒ and deep sequencing of the 6 genes in 84 flax samples was performed on MiSeq. The obtainedΒ high coverageΒ (about 400x on average) enabled accurate assessment of polymorphisms in SAD1, SAD2, FAD2A, FAD2B, FAD3A, and FAD3B genes and evaluation of cultivar/line heterogeneity. The highest level of genetic diversity was observed for FAD3A and FAD3B genes β 91 and 62 polymorphisms respectively. Correlation analysis revealed associations between particular variants in SAD and FAD genes and predominantly those fatty acids whose conversion they catalyze: SAD β stearic and oleic acids, FAD2 β oleic and linoleic acids, FAD3 β linoleic and linolenic acids. All except one low-linolenic flax cultivars/lines contained both the substitution of tryptophan to stop codon in the FAD3A gene and histidine to tyrosine substitution in the FAD3B gene, while samples with only one of these polymorphisms had medium content of linolenic acidΒ and cultivars/lines without them were high-linolenic. Conclusions: Genetic polymorphism of SAD and FAD genes was evaluated in the collection of flax cultivars and lines with diverse oil composition, and associations between particular polymorphisms and the ratio of fatty acids were revealed. The achieved results are the basis for the development of marker-assisted selection and DNA-based certification of flax cultivars. Β© 2020, The Author(s)